NRD
HALO icon

Nebula Research & Development’s Halozyme HALO Stock Holding History

Nebula Research & Development’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,264
Closed -$988K – 983
2024
Q3 		$988K Buy
+17,264
New +$990K 0.12% 295
2024
Q1 		– Sell
-6,380
Closed -$236K – 834
2023
Q4 		$236K Buy
+6,380
New +$240K 0.07% 509
2023
Q3 		– Sell
-14,078
Closed -$508K – 564
2023
Q2 		$508K Buy
14,078
+6,333
+82% +$216K 0.38% 128
2023
Q1 		$296K Buy
+7,745
New +$363K 0.52% 112

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nebula Research & Development's HALO Position: Q4 2024 in Review

Nebula Research & Development sold out of Halozyme (HALO) in Q4 2024, closing a stake of 17,264 shares — an estimated $988K sold.

Nebula Research & Development first reported a position in HALO in Q1 2023 and held it in 4 quarters. The position peaked at $988K in Q3 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Nebula Research & Development reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Nebula Research & Development sold 17,264 Halozyme shares in Q4 2024, an estimated $988K.
  • Nebula Research & Development first reported a position in Halozyme in Q1 2023 and held it in 4 quarters.
  • Nebula Research & Development's Halozyme position peaked at $988K in Q3 2024.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Nebula Research & Development's 13F filing for Q4 2024, filed 14 Feb 2025.